Cargando…
Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation
There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester af...
Autores principales: | Hill, Meghan G., Sekhon, Mehtab K., Reed, Kathryn L., Anderson, Caroline F., Borjon, Nydia D., Tardiff, Jil C., Barber, Brent J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655206/ https://www.ncbi.nlm.nih.gov/pubmed/26337809 http://dx.doi.org/10.1007/s00246-015-1250-1 |
Ejemplares similares
-
Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010) -
Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021) -
Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance
por: Liu, Hui-Ting, et al.
Publicado: (2019) -
Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy
por: Wang, Bo, et al.
Publicado: (2019) -
Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant
por: Serra, Walter, et al.
Publicado: (2022)